137 related articles for article (PubMed ID: 16575403)
1. Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer.
Ueda S; Hatsuse K; Tsuda H; Ogata S; Kawarabayashi N; Takigawa T; Einama T; Morita D; Fukatsu K; Sugiura Y; Matsubara O; Mochizuki H
Mod Pathol; 2006 Jun; 19(6):788-96. PubMed ID: 16575403
[TBL] [Abstract][Full Text] [Related]
2. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.
Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H
Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117
[TBL] [Abstract][Full Text] [Related]
3. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.
Hirakawa T; Yashiro M; Murata A; Hirata K; Kimura K; Amano R; Yamada N; Nakata B; Hirakawa K
BMC Cancer; 2013 Aug; 13():392. PubMed ID: 23962053
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.
Mahipal A; Mcdonald MJ; Witkiewicz A; Carr BI
Med Oncol; 2012 Mar; 29(1):134-9. PubMed ID: 21264542
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas.
Wu PF; Huang WC; Yang JC; Lu YS; Shih JY; Wu SG; Lin CH; Cheng AL
J Neurooncol; 2013 Oct; 115(1):61-70. PubMed ID: 23817810
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
Cappuzzo F; Tallini G; Finocchiaro G; Wilson RS; Ligorio C; Giordano L; Toschi L; Incarbone M; Cavina R; Terracciano L; Roncalli M; Alloisio M; Varella-Garcia M; Franklin WA; Santoro A
Ann Oncol; 2010 Mar; 21(3):562-567. PubMed ID: 19767315
[TBL] [Abstract][Full Text] [Related]
8. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas.
Gallardo A; Lerma E; Escuin D; Tibau A; Muñoz J; Ojeda B; Barnadas A; Adrover E; Sánchez-Tejada L; Giner D; Ortiz-Martínez F; Peiró G
Br J Cancer; 2012 Apr; 106(8):1367-73. PubMed ID: 22454081
[TBL] [Abstract][Full Text] [Related]
9. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of IGF1R expression in non-small-cell lung cancer.
Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
Gilbert JA; Adhikari LJ; Lloyd RV; Halfdanarson TR; Muders MH; Ames MM
Pancreas; 2013 Apr; 42(3):411-21. PubMed ID: 23211371
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
[TBL] [Abstract][Full Text] [Related]
13. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis.
Perini MV; Montagnini AL; Coudry R; Patzina R; Penteado S; Abdo EE; Diniz A; Jukemura J; da Cunha JE
ANZ J Surg; 2015 Mar; 85(3):174-8. PubMed ID: 24112413
[TBL] [Abstract][Full Text] [Related]
16. A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Makimoto G; Ninomiya K; Kubo T; Sunami R; Kato Y; Ichihara E; Ohashi K; Rai K; Hotta K; Tabata M; Maeda Y; Kiura K
Jpn J Clin Oncol; 2021 May; 51(6):956-965. PubMed ID: 33829270
[TBL] [Abstract][Full Text] [Related]
17. Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma.
Liu Z; Teng XY; Meng XP; Wang BS
World J Surg Oncol; 2014 Nov; 12():348. PubMed ID: 25407240
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.
Wu H; Zhu L; Zhang H; Shi X; Zhang L; Wang W; Xue H; Liang Z
PLoS One; 2015; 10(2):e0116803. PubMed ID: 25679210
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
Inno A; Di Salvatore M; Cenci T; Martini M; Orlandi A; Strippoli A; Ferrara AM; Bagalà C; Cassano A; Larocca LM; Barone C
Clin Colorectal Cancer; 2011 Dec; 10(4):325-32. PubMed ID: 21729677
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Valsecchi ME; McDonald M; Brody JR; Hyslop T; Freydin B; Yeo CJ; Solomides C; Peiper SC; Witkiewicz AK
Cancer; 2012 Jul; 118(14):3484-93. PubMed ID: 22086503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]